341. 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
作者: Latha P Palaniappan.;Norrina B Allen.;Zaid I Almarzooq.;Cheryl A M Anderson.;Pankaj Arora.;Christy L Avery.;Carissa M Baker-Smith.;Nisha Bansal.;Maria E Currie.;Rebecca S Earlie.;Wenjun Fan.;Jessica L Fetterman.;Bethany Barone Gibbs.;Debra G Heard.;Swapnil Hiremath.;Haoyun Hong.;Hyacinth I Hyacinth.;Chinwe Ibeh.;Tian Jiang.;Michelle C Johansen.;Dhruv S Kazi.;Darae Ko.;Tak W Kwan.;Michelle H Leppert.;Yilun Li.;Jared W Magnani.;Karlyn A Martin.;Seth S Martin.;Erin D Michos.;Michael E Mussolino.;Oluwabunmi Ogungbe.;Nisha I Parikh.;Marco V Perez.;Sarah M Perman.;Ashish Sarraju.;Nilay S Shah.;Mellanie V Springer.;Marie-Pierre St-Onge.;Evan L Thacker.;Seda Tierney.;Sarah M Urbut.;Harriette G C Van Spall.;Jenifer H Voeks.;Seamus P Whelton.;Sally S Wong.;Juan Zhao.;Sadiya S Khan.; .
来源: Circulation. 2026年153卷9期e275-e906页
The American Heart Association annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and cardiovascular-kidney-metabolic syndrome) that contribute to cardiovascular health. The 2026 Heart Disease and Stroke Statistics Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).
342. Correction to "Intravascular Imaging-Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation".
作者: Evan Shlofmitz.;Ziad A Ali.;Akiko Maehara.;Gary S Mintz.;Richard Shlofmitz.;Allen Jeremias.
来源: Circ Cardiovasc Interv. 2026年19卷1期e000099页 344. Zipping Versus Clover Repair in Transcatheter Edge-to-Edge Tricuspid Repair: Insights From the TRI-SPA Registry.
作者: Julio Echarte-Morales.;Manuel Barreiro-Pérez.;Xavier Freixa.;Dabit Arzamendi.;Vanessa Moñivas.;Fernando Carrasco-Chinchilla.;Manuel Pan.;Luis Nombela-Franco.;Isaac Pascual.;Tomás Benito-González.;Ruth Pérez.;Iván Gómez-Blázquez.;Ignacio J Amat-Santos.;Ignacio Cruz-González.;Ángel Sánchez-Recalde.;Ana Belén Cid Álvarez.;Laura Sanchis.;Berenice Caneiro-Queija.;Chi Hion Li.;Maria Del Trigo.;José David Martínez-Carmona.;Dolores Mesa.;Pilar Jiménez.;Pablo Avanzas.;Pedro Cepas-Guillén.;Rodrigo Estévez-Loureiro.
来源: Circ Cardiovasc Interv. 2026年19卷1期e015771页
Transcatheter edge-to-edge repair is an established treatment for tricuspid regurgitation (TR) in nonoptimal surgical candidates. Two techniques have been described: zipping (or bicuspidization) and clover (or triple-orifice). This study aimed to compare the echocardiographic and clinical outcomes of these 2 techniques.
345. Correction to: Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial.
作者: Anping Cai.;Antoni Bayes-Genis.;Joanne Ryan.;Yingqing Feng.;James L Januzzi.;Andrew M Tonkin.;Jiazhen Zheng.;Mark R Nelson.;Johannes T Neumann.;Robyn L Woods.;Cammie Tran.;Aletta E Schutte.;Ambarish Pandey.;Lin Yee Chen.;Lin Liu.;Junguo Zhang.;John J McNeil.;Lawrence Beilin.;Hung-Fat Tse.;Gianfranco Parati.;Zhen Zhou.
来源: Circulation. 2026年153卷3期e20页 349. Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
作者: Nikolaos Pyrpyris.;Kyriakos Dimitriadis.;Konstantinos Tsioufis.
来源: Circulation. 2026年153卷3期e14-e15页 350. Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
作者: Michael Maeng.;Pernille G Thrane.;David Erlinge.;Akiko Maehara.;Gregg W Stone.
来源: Circulation. 2026年153卷3期e17-e18页 353. Correction to: "Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction".
作者: Carlos G Santos-Gallego.;Juan Antonio Requena-Ibáñez.;Belen Picatoste.;Brian Fardman.;Kiyotake Ishikawa.;Renata Mazurek.;Michael Pieper.;Samantha Sartori.;Jorge Rodriguez-Capitán.;Valentin Fuster.;Juan J Badimon.
来源: Circ Cardiovasc Imaging. 2026年19卷1期e000090页 357. Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation.
作者: Thomas Münzel.;Thomas Lüscher.;Christopher M Kramer.;Keith Churchwell.;Amam Mbakwem.;Sanjay Rajagopalan.
来源: Circulation. 2026年153卷8期597-604页
Non-communicable diseases (NCDs) account for 70% of global mortality and are responsible for over 38 million deaths annually, with cardiovascular disease (CVD) constituting most of these fatalities. While traditional risk factors for CVD have long been recognized, there is growing evidence that a rising prevalence of ubiquitous environmental risk factors (ERFs) may play an increasingly significant role in the genesis and rising prevalence of NCDs. ERFs include many interconnected anthropogenic exposures with cumulative compound health impacts, including air pollution, noise exposure, artificial light at night, plastic pollution, chemical pollution and the various effects of climate change, such as heat extremes, desert storms, floods and wildfires. Urbanization has intensified the impact of many ERFs and created intense exposure environments, highlighting the urgency and the opportunity to address these for maximum public health benefit. Impactful intervention often requires regulatory and policy-driven efforts addressing the genesis of exposures and minimizes their health impact, particularly in vulnerable populations who may contribute the least but may be impacted the most. Solutions must involve the development of resiliency and adaptation measures to a changing world, where the probability of sudden catastrophic and cascading events is much more likely. Political will and international cooperation are essential in establishing and enforcing regulations that promote cleaner air and water, quieter and natural biodiverse environments, and sustainable infrastructure in urban, and rural medical facilities. Integration of planetary and environmental health into cardiovascular care will be vital in reducing the burden of NCDs globally. By addressing the root causes of environmental stressors, it is possible to reduce the incidence of CVDs and promote healthier, just and sustainable societies.
358. Elevated Resting Coronary Blood Flow Is Associated With Death, MI, and HF in All-Comer Patients With Chronic Coronary Syndrome.
作者: Shajan Shekarestan.;Fadi Jokhaji.;Christina Ekenbäck.;Mattias Törnerud.;Samantha Lörstad.;Petter Ljungman.;Nikolaos Östlund-Papadogeorgos.;Rikard Linder.;Bassem Samad.;Jonas Persson.
来源: Circ Cardiovasc Interv. 2026年19卷2期e015867页
The prognostic implications of bolus thermodilution-derived resting coronary blood flow in all-comer patients with chronic coronary syndrome are not known. We investigated the association of thermodilution-derived indices characterizing coronary flow with outcomes.
359. Socioeconomic and Structural Barriers to Addressing Obesity in Communities: A Scientific Statement From the American Heart Association.
作者: Stephanie T Chung.;Josephine Harrington.;Namratha R Kandula.;Kiarri N Kershaw.;Morgana Mongraw-Chaffin.;Foster Osei Baah.;Angela F Pfammatter.;Michael V Stanton.;Fatima Cody Stanford.; .
来源: Circulation. 2026年153卷8期e252-e262页
The obesity epidemic continues largely unabated, affecting more than one-third of the US population and disproportionately burdening individuals from socioeconomically disadvantaged populations. Numerous factors contribute to the high prevalence of obesity, including socioeconomic and structural barriers impeding primordial and primary prevention efforts. Despite broad recognition that social determinants of health are key drivers of obesity, the importance of socioeconomic and structural factors as contemporary barriers to individual-, community-, and population-level obesity prevention and intervention efforts remains underappreciated. This scientific statement highlights multilevel barriers to obesity prevention and management, with an emphasis on social determinants of health, societal culture, and shared biases that may interfere with the success of healthy weight management programs. The assessment includes a comprehensive review of policy and community-level strategies used to address the obesity epidemic and identifies key areas for future research.
|